We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $697M
1-Year Est. Return 79.73%
This Fund
S&P 500
This Quarter Est. Return
-7.37%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$310M
AUM Growth
-$104M
Cap. Flow
-$74.9M
Cap. Flow %
-24.14%
Top 10 Hldgs %
43.58%
Holding
95
New
25
Increased
9
Reduced
24
Closed
33

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$18.9M
2
AGN
Allergan plc
AGN
+$16.4M
3
PFE icon
Pfizer
PFE
+$11M
4
MCK icon
McKesson
MCK
+$8.96M
5
COR icon
Cencora
COR
+$8.86M

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$15.2M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
+$12.1M
3
MEDP icon
Medpace
MEDP
+$10.2M
4
NVS icon
Novartis
NVS
+$8.3M
5
HUM icon
Humana
HUM
+$7.51M

Sector Composition

Rank Sector Weight
1 Healthcare 82.23%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MEDP icon
26
Medpace
MEDP
$16.1B
$4.32M 1.39%
51,401
-134,414
-72% -$10.2M
CERN
27
PUT
DELISTED
Cerner Corp
CERN
$4.25M 1.37%
62,300
-46,700
-43% -$3.31M
HRC
28
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$4.23M 1.36%
40,182
-2,000
-5% -$211K
HSIC icon
29
PUT
Henry Schein
HSIC
$9.77B
$4.13M 1.33%
+65,000
New +$4.2M
NVO
30
Novo Nordisk
NVO
$208B
$4.09M 1.32%
+158,200
New +$4M
RVNC
31
DELISTED
Revance Therapeutics, Inc.
RVNC
$3.97M 1.28%
305,664
-98,000
-24% -$1.2M
ITGR icon
32
Integer Holdings
ITGR
$4.12B
$3.82M 1.23%
50,596
-5,248
-9% -$415K
MOH icon
33
Molina Healthcare
MOH
$10.2B
$3.56M 1.15%
32,490
+2,490
+8% +$323K
CCRN
34
DELISTED
Cross Country Healthcare
CCRN
$3.37M 1.09%
327,466
+68,739
+27% +$676K
HSACU
35
DELISTED
Health Sciences Acquisitions Corporation Units
HSACU
$3.29M 1.06%
307,000
– –
GKOS icon
36
PUT
Glaukos
GKOS
$9.83B
$3.24M 1.04%
+51,800
New +$3.65M
AMRN
37
Amarin Corp
AMRN
$299M
$3.14M 1.01%
+10,370
New +$3.62M
ICLR icon
38
Icon
ICLR
$12.6B
$3.02M 0.97%
20,530
-10,000
-33% -$1.54M
SYNH
39
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$2.84M 0.91%
53,297
-72,602
-58% -$3.73M
FOMX
40
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$2.8M 0.9%
920,796
-374,873
-29% -$1.05M
XRAY icon
41
PUT
Dentsply Sirona
XRAY
$2.68B
$2.67M 0.86%
+50,000
New +$2.69M
SPPI
42
CALL
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$2.43M 0.78%
+292,700
New +$2.37M
ARNA
43
DELISTED
Arena Pharmaceuticals Inc
ARNA
$2.01M 0.65%
+43,857
New +$2.47M
PINC
44
DELISTED
Premier
PINC
$1.98M 0.64%
+68,597
New +$2.56M
HROW icon
45
Harrow
HROW
$1.45B
$1.9M 0.61%
338,614
-132,500
-28% -$868K
UROV
46
DELISTED
Urovant Sciences Ltd.
UROV
$1.79M 0.58%
188,842
-31,200
-14% -$271K
XCUR icon
47
Exicure
XCUR
$10.2M
$1.71M 0.55%
+4,498
New +$1.72M
DVAX
48
DELISTED
Dynavax Technologies
DVAX
$1.66M 0.54%
+465,299
New +$1.8M
PFNX
49
DELISTED
Pfenex Inc.
PFNX
$1.63M 0.53%
193,608
-20,000
-9% -$145K
ATNM icon
50
Actinium Pharmaceuticals
ATNM
$26.3M
$1.38M 0.44%
200,105
+35,597
+22% +$248K
1
2
3 4

Similar funds

GUB
Golden Unicorn BVI Road Town $697M AUM 55.92% 1-Year Est. Return
KLI
Kelman-Lazarov Inc Memphis, Tennessee $698M AUM 14.07% 1-Year Est. Return
JA
JLB & Associates Plymouth, Michigan $696M AUM 17.86% 1-Year Est. Return
WIC
Wilkins Investment Counsel Boston, Massachusetts $698M AUM 17.36% 1-Year Est. Return
AAM
Auxier Asset Management Aurora, Oregon $696M AUM 18.07% 1-Year Est. Return
TCM
Tensile Capital Management Larkspur, California $698M AUM 2.4% 1-Year Est. Return
CA
Calton & Associates Tampa, Florida $696M AUM 18.3% 1-Year Est. Return
SAM
Silverback Asset Management Chapel Hill, North Carolina $699M AUM 72.42% 1-Year Est. Return

Sio Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Sio Capital Management held 95 positions worth $310M, down 25% from $415M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Sio Capital Management withdrew a net $74.9M in Q3 2019, closing 33 positions and reducing 24 holdings. Its most notable exit was GSK, an estimated $15.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 69% a quarter earlier, followed by Technology.

Against the trend, Sio Capital Management opened a new position in Johnson & Johnson worth $18.6M.

  • Sio Capital Management's largest Q3 2019 buy was Johnson & Johnson: 143,707 shares worth $18.6M.
  • Sio Capital Management added most to GW Pharmaceuticals Plc American Depositary Shares in Q3 2019, an estimated $8.43M increase.
  • Sio Capital Management's biggest Q3 2019 reduction was Medpace, cutting an estimated $10.2M.
  • Sio Capital Management fully exited GSK in Q3 2019, selling an estimated $15.2M.
  • Sio Capital Management's ten largest holdings make up 44% of its $310M portfolio in Q3 2019.
  • Sio Capital Management opened 25 new positions and closed 33 in Q3 2019.
  • Sio Capital Management's portfolio value fell 25% quarter-over-quarter to $310M.

Based on Sio Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.